Peter Maurice, MD
Otolaryngology · Burien, WANPI 1518974781
Payments from drug & device makers
What this record shows
Medtronic accounts for 77.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $2,920 and has fallen 95.9% since, to $120 in 2025. Among otolaryngology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 35 payments — averaging $120.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Inspire Medical Systems, Inc.$545
- Alk-abello, Inc$175
- Neurent Medical Limited$119
- Acclarent, Inc$36
- Regeneron Healthcare Solutions, Inc.$32
- plus $63 from 3 others
What the payments were for
- Travel & lodging$2,41457%
- Food & beverage$1,80643%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 11 | $3,251 |
| Inspire Medical Systems, Inc. | 14 | $545 |
| Alk-abello, Inc | 4 | $175 |
| Neurent Medical Limited | 1 | $119 |
| Acclarent, Inc | 1 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Stryker | 1 | $22 |
| Sanofi | 1 | $22 |
| Intersect ENT, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROPEL$1,533
- SINUVA$1,357
- Inspire$147
- Inspire Upper Airway Stimulation System$132
- FUSION$130
- NIM Vital$122
- NEUROMARK Device$119
- NEUROMARK Radiofrequency Console$119
How this compares
$4,220 in reported general payments places this provider in the 90th percentile of 254 otolaryngology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 82 | $1,938 |
| Omeprazole | 137 | $1,273 |
| Ofloxacin | 39 | $1,008 |
| Fluocinolone Acetonide Oil | 18 | $1,005 |
| Famotidine | 75 | $786 |
| Mupirocin | 71 | $725 |
| CefuroximeCefuroxime Axetil | 31 | $535 |
| Fluticasone Propionate | 53 | $436 |
| Cephalexin | 67 | $368 |
| Ondansetron OdtOndansetron | 58 | $338 |
| Doxycycline Hyclate | 30 | $312 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 52 | $293 |
| Pantoprazole Sodium | 15 | $251 |
| Mometasone Furoate | 34 | $249 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $195 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Burien
- Chad RuffinBurien$3K
- Greg DavisPuyallup$531K
- Ian HumphreysSeattle$43K
- Douglas BackousPuyallup$36K
- Craig MillerSeattle$24K
- Sachin GuptaSeattle$23K
- Sharon CushingSeattle$19K
- Ronald KruegerMukilteo$19K
- Eric WatermanBellevue$15K
- Ryan SternFederal Way$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.